Vivos Therapeutics (VVOS) Other Non Operating Income (2021 - 2026)
Vivos Therapeutics (VVOS) reported Other Non Operating Income of -$1.2 million for Q1 2026, down 29075.0% year-over-year from N/an in Q1 2025, and down 84.94% on a QoQ basis from -$631000.0 in Q4 2025.
Vivos Therapeutics (VVOS) has 6 years of Other Non Operating Income data on file, last reported at -$1.2 million in Q1 2026.
- Quarterly Other Non Operating Income fell 29075.0% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 2257.14% YoY) and the FY2025 annual result came in at -$1.5 million, down 1246.36% from the prior year.
- Other Non Operating Income fell to -$1.2 million in Q1 2026 per VVOS's latest filing, from -$631000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $51000.0 in Q1 2023 and bottomed at -$1.2 million in Q1 2026.
- The 5-year median for Other Non Operating Income is -$38000.0 (2022), against an average of -$184882.4.
- The widest annual swing landed in 2023, when Other Non Operating Income soared 234.21%; it then sank 29075.0% in 2026.
- Tracing VVOS's Other Non Operating Income over 5 years: stood at -$38000.0 in 2022, then soared by 63.16% to -$14000.0 in 2023, then slumped by 385.71% to -$68000.0 in 2024, then sank by 827.94% to -$631000.0 in 2025, then plunged by 84.94% to -$1.2 million in 2026.
- Per Business Quant, the three latest VVOS Other Non Operating Income figures stand at -$1.2 million (Q1 2026), -$631000.0 (Q4 2025), and -$679000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.17 Mn |
| Dec 31, 2025 | -631,000.00 |
| Sep 30, 2025 | -679,000.00 |
| Jun 30, 2025 | -163,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -68,000.00 |
| Sep 30, 2024 | -18,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | -53,000.00 |
| Jun 30, 2023 | -225,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | -38,000.00 |
| Sep 30, 2022 | -36,000.00 |
| Jun 30, 2022 | -37,000.00 |
| Mar 31, 2022 | -38,000.00 |
| Dec 31, 2021 | -95,000.00 |
| Sep 30, 2021 | 59,000.00 |
| Jun 30, 2021 | 19,000.00 |
| Mar 31, 2021 | 8,000.00 |